Menopause and brain health: memory, dementia risk and what is known

Many women notice slower recall and patchier concentration in perimenopause, and the best long-term study suggests this is real but usually temporary: performance tends to recover after menopause. Whether menopause raises the risk of dementia is less clear. Women make up most people with Alzheimer’s, but hormone therapy has not been shown to prevent it, and the strongest levers for long-term brain health are the same ones that protect the heart.

Brain fog in perimenopause: what the research shows

SWAN, the Study of Women’s Health Across the Nation, tested 2,362 women for four years on processing speed, verbal memory and working memory. Normally, people score a little higher each time they repeat a test because they learn it. That learning effect showed up in premenopausal and postmenopausal women, but it stalled in perimenopause:

• Processing speed improved with repeat testing in every stage except late perimenopause.
• Delayed verbal recall improved before and after menopause but not during early or late perimenopause.
• After menopause, performance in women not using hormones was indistinguishable from that of premenopausal women.

The authors concluded that the transition is linked to a measurable dip in the ability to learn new material, consistent with what many women report, and that the difficulty appears to be time-limited. Our guide to brain fog covers practical strategies.

Hot flashes and sleep are part of the story. The Menopause Society notes that vasomotor symptoms are associated with poorer sleep, irritability and difficulty concentrating. Frequent hot flashes lasted an average of 7.4 years in SWAN, and the society notes they appear to be linked to cardiovascular, bone and cognitive risks, though whether treating them protects the brain long term is not known. In the short term, treating night sweats, insomnia and low mood is often the most direct way to think more clearly, whether you use hormone therapy or a non-hormonal option.

SWAN also found that women who used hormones before their final period scored somewhat higher, while those who started after it scored lower. Because this was observational, it cannot show cause and effect, and later randomized trials did not confirm a benefit.

Dementia: the numbers

According to the Alzheimer’s Association’s 2026 Facts and Figures:

• An estimated 7.4 million Americans 65 and older are living with Alzheimer’s disease.
• Almost two-thirds of them are women.
• The lifetime risk of Alzheimer’s at age 45 is 1 in 5 for women and 1 in 10 for men.

Living longer is one reason women are affected more often. Whether the hormonal changes of menopause also contribute is an active research question without a settled answer.

Early loss of ovarian function is different. The Menopause Society’s 2022 statement lists an increased risk of dementia among the health effects of premature menopause, early menopause and primary ovarian insufficiency. It also notes that estrogen may have cognitive benefits when started right after hysterectomy with removal of both ovaries. See surgical menopause.

What the hormone therapy trials found

Trial	Who took part	Treatment	Cognitive result
WHI Memory Study (2003)	4,532 women aged 65 and older	Oral conjugated estrogens plus medroxyprogesterone vs placebo, about 4 years	Probable dementia doubled (hazard ratio 2.05): 45 vs 22 cases per 10,000 women per year. No effect on mild cognitive impairment
KEEPS and KEEPS Continuation (2024)	Healthy women within 3 years of their final period	Oral conjugated estrogens or transdermal estradiol vs placebo for 4 years	No benefit or harm at 4 years, or about 10 years later in 275 women retested

The two trials differ in age at the start of treatment. That fits the “timing hypothesis,” the idea that estrogen may help the brain if started early but harm it if started late. The Menopause Society says neither this nor competing explanations has been definitively proven in randomized trials of postmenopausal women.

The Menopause Society’s conclusions:

• Hormone therapy is not recommended at any age to prevent or treat cognitive decline or dementia.
• Starting hormone therapy after 65 increased dementia risk, with 23 extra cases per 10,000 women per year in the WHI Memory Study.
• Three large trials found neutral effects on cognition when therapy was used early in postmenopause.

In short, hormone therapy taken for hot flashes in your late 40s or 50s does not appear to harm thinking skills, but it should not be taken to protect them. For the wider risk picture, read is hormone therapy safe?.

What lowers dementia risk

The 2024 Lancet Commission on dementia prevention identified 14 potentially modifiable risk factors and estimated that together they account for about 45% of dementia worldwide:

Life stage	Risk factors
Early life	Less education
Midlife	Hearing loss, high LDL cholesterol, depression, traumatic brain injury, physical inactivity, diabetes, smoking, high blood pressure, obesity, excessive alcohol
Later life	Social isolation, air pollution, untreated vision loss

Most of the list belongs to midlife, which is the stage of perimenopause and menopause. Concrete steps:

• Keep blood pressure in range. The 2025 US guideline endorses a systolic goal below 130 mm Hg partly to reduce the risk of mild cognitive impairment and dementia; see blood pressure in midlife women.
• Check your hearing and use hearing aids if you need them.
• Know your LDL cholesterol and blood sugar, both of which shift in midlife.
• Treat depression rather than dismissing low mood as just hormones.
• Stay physically active, including strength training.
• Do not smoke, and keep alcohol modest.
• Protect your head during sports and cycling, and get your vision checked.
• Stay socially connected, which matters more with age.

When to see a clinician

Seek an evaluation if memory or thinking problems are getting steadily worse, if they interfere with work, finances or daily tasks, if others notice changes in your personality or judgment, or if you get lost in familiar places. A clinician can look for treatable contributors such as poor sleep, depression, thyroid problems or medication side effects.

Call 911 for sudden confusion, trouble speaking, facial drooping, or weakness or numbness on one side, which can signal a stroke.

You can find a menopause-literate clinician to talk through symptoms and hormone therapy in our directory.